Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial

• Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies · 2024

• Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity · 2021

• A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia · 2021

• Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease · 2019

• Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada · 2015

• Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease · 2009

• The Hawthorne Effect: a randomised, controlled trial · 2007

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.